Key facts
- It has raised $11.6M; the latest was Later Stage VC ($3.5M) in Feb 2026.
- Notable investors include Plug and Play Tech Center, European Innovation Council, MedTech Innovator, Brabantse Ontwikkelings Maatschappij, Oost NL — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for ATRO Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for ATRO Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ATRO Medical
Developer of a meniscus prosthesis designed to replace the damaged meniscus with an implantable prosthesis. The company's prosthesis is a synthetic, non-resorbable substitute that mimics the function of the natural meniscus and functions as a shock absorber by adequate load distribution within the knee joint, enabling osteoarthritis patients to get relief from severe pain and improve life.
- Sector
- Healthcare
- HQ
- Nijmegen, Netherlands
- Founded
- 2016
- Employees
- 9
- Website
- atromedical.com/
- Ownership
- Privately Held (backing)
ATRO Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ATRO Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ATRO Medical in its N-PORT filings yet. We sweep new filings monthly.